MXPA05010417A - Composiciones topicas de l-carnitina. - Google Patents

Composiciones topicas de l-carnitina.

Info

Publication number
MXPA05010417A
MXPA05010417A MXPA05010417A MXPA05010417A MXPA05010417A MX PA05010417 A MXPA05010417 A MX PA05010417A MX PA05010417 A MXPA05010417 A MX PA05010417A MX PA05010417 A MXPA05010417 A MX PA05010417A MX PA05010417 A MXPA05010417 A MX PA05010417A
Authority
MX
Mexico
Prior art keywords
carnitine
skin
topical composition
acyl
topical
Prior art date
Application number
MXPA05010417A
Other languages
English (en)
Spanish (es)
Inventor
Guth Jacob
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of MXPA05010417A publication Critical patent/MXPA05010417A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA05010417A 2003-03-28 2004-03-29 Composiciones topicas de l-carnitina. MXPA05010417A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45882203P 2003-03-28 2003-03-28
PCT/US2004/009591 WO2004087072A2 (en) 2003-03-28 2004-03-29 Topical l-carnitine compositions

Publications (1)

Publication Number Publication Date
MXPA05010417A true MXPA05010417A (es) 2005-11-04

Family

ID=33131830

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010417A MXPA05010417A (es) 2003-03-28 2004-03-29 Composiciones topicas de l-carnitina.

Country Status (13)

Country Link
US (1) US20050100519A1 (cg-RX-API-DMAC7.html)
EP (1) EP1610760A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006522807A (cg-RX-API-DMAC7.html)
KR (1) KR20050113669A (cg-RX-API-DMAC7.html)
CN (1) CN1964695A (cg-RX-API-DMAC7.html)
AU (1) AU2004226324A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0408834A (cg-RX-API-DMAC7.html)
CA (1) CA2519998A1 (cg-RX-API-DMAC7.html)
EA (1) EA200501413A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05010417A (cg-RX-API-DMAC7.html)
NO (1) NO20054465L (cg-RX-API-DMAC7.html)
WO (1) WO2004087072A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200507824B (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416869B2 (en) * 2004-08-19 2008-08-26 Lonza Ltd. Enzyme delivery systems, application in water based products
ITMI20041603A1 (it) * 2004-08-04 2004-11-04 Vama Farmacosmetica S R L Materia prima cosmetica a base di 1-carnitina per preparato ad effetto idratante di lunga durata e preparato cosmetico ottenuto con questa materia prima
EP1649846A1 (de) * 2004-10-21 2006-04-26 Neubourg Skin Care GmbH & Co. KG Verwendung von Harnstoff zur Behandlung von Altersflecken
KR101165848B1 (ko) * 2005-08-18 2012-07-13 (주)아모레퍼시픽 효소 및 아미노산을 함유하는 피부 화장료 조성물
MX2008014784A (es) 2006-05-19 2009-01-30 Mary Kay Inc Compuestos de glicerilo y acido glicolico.
TW200831125A (en) * 2006-12-08 2008-08-01 Pola Chem Ind Inc A discrimination method of skin barrier function, the screening method of skin barrier function reinforced material by using the discrimination method, the skin barrier function reinforced materials, and the cosmetic material containing the skin barrier
CN101677912B (zh) * 2007-05-11 2013-06-12 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶
JP2012508267A (ja) * 2008-11-11 2012-04-05 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ セルライトの処置に有用な化合物
KR101017586B1 (ko) * 2008-11-28 2011-02-28 (주)아모레퍼시픽 피부 미백용 화장료 조성물
FR2949969B1 (fr) * 2009-09-11 2012-08-03 Svr Lab Composition cosmetique a base d'uree pure, utilisation et procede d'application correspondant
DE102012214038A1 (de) * 2012-08-08 2014-02-13 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus Harnstoff und Car-ni-tin und/oder einem oder mehreren Acyl-Carnitinen zur Behandlung und Prophylaxe von Neurodermitis sowie des diabetischen Fußes
KR102158895B1 (ko) 2013-03-12 2020-09-22 마리 케이 인코포레이티드 보존 시스템
CN106102838A (zh) * 2014-06-02 2016-11-09 雅芳产品公司 局部用增亮组合物及其使用方法
ES2815659T3 (es) 2014-08-18 2021-03-30 Pan Montojo Francisco El ácido glicólico mejora la motilidad del esperma
ES2910653T3 (es) * 2015-01-27 2022-05-13 Professional Dietetics S P A In Forma Abbreviata P D S P A Composiciones que comprenden a) quitosano, b) ácido glicólico, c) carnitina y/o n-acetilcisteína para el tratamiento de descamación dermoepidérmica
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
KR101934022B1 (ko) * 2017-12-04 2018-12-31 주식회사 엘지생활건강 피부 각질 박리 촉진용 화장용 조성물
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
CN119157765A (zh) * 2018-07-17 2024-12-20 株式会社Lg生活健康 组合物在制造化妆品中的应用以及增强角质剥离的方法
KR102253135B1 (ko) * 2018-07-17 2021-05-17 주식회사 엘지생활건강 각질 박리 증진용 화장료 조성물
KR102771004B1 (ko) * 2018-10-17 2025-02-21 주식회사 엘지생활건강 피부 각질 박리 촉진용 화장료 조성물
CN109528628B (zh) * 2018-12-14 2022-02-08 北京中医药大学 一种包含左卡尼汀的药用组合物及其制备方法和用途
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
CA3199921A1 (en) * 2020-11-25 2022-06-02 Steven M. Hernandez Scar treatment composition
US20240173232A1 (en) * 2021-03-08 2024-05-30 Lg Household & Health Care Ltd. Cosmetic composition comprising carnitine-salicylate as active ingredient
CN116981438A (zh) * 2021-03-08 2023-10-31 株式会社Lg生活健康 包含肉碱水杨酸盐作为有效成分的化妆料组合物
JPWO2025258571A1 (cg-RX-API-DMAC7.html) * 2024-06-12 2025-12-18

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683939A (en) * 1970-05-28 1972-08-15 Wilson Pharm & Chem Corp Proteinaceous cosmetic material for hair conditioning
JPS51148042A (en) * 1975-06-14 1976-12-18 Kanebo Ltd Skin toiletry
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
JPH0615462B2 (ja) * 1989-01-12 1994-03-02 レイコ 小阪 毛髪用組成物
IT1261984B (it) * 1993-06-22 1996-06-11 Avantgarde Spa Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
JPH07157409A (ja) * 1993-12-07 1995-06-20 Kobe Steel Ltd 美白性化粧料
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
JP3229517B2 (ja) * 1995-04-18 2001-11-19 カネボウ株式会社 美白化粧料
JPH09263514A (ja) * 1996-03-29 1997-10-07 Shiseido Co Ltd 皮膚外用剤
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
JPH1129457A (ja) * 1997-07-04 1999-02-02 Kanebo Ltd 皮膚化粧料
JPH11180851A (ja) * 1997-12-22 1999-07-06 Kanebo Ltd 皮膚化粧料
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19806947A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
JP3229594B2 (ja) * 1998-12-16 2001-11-19 カネボウ株式会社 美白化粧料
JP3874966B2 (ja) * 1999-05-11 2007-01-31 株式会社カネボウ化粧品 シート状美白パック化粧料
US6416769B1 (en) * 2000-03-03 2002-07-09 Australian Importers, Ltd. Cosmetic compositions comprising exfoliating enzymes and uses thereof
AU2001259158A1 (en) * 2000-05-02 2001-11-12 Nicholas V. Perricone Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters
DE10129504A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe von Pigmentierungsstörungen
WO2003041667A2 (en) * 2001-11-13 2003-05-22 The Procter & Gamble Company Compositions containing enzymes stabilized with certain osmo-protectants and methods for using such compositions in personal care

Also Published As

Publication number Publication date
NO20054465D0 (no) 2005-09-27
NO20054465L (no) 2005-12-12
EP1610760A2 (en) 2006-01-04
WO2004087072A3 (en) 2006-04-27
BRPI0408834A (pt) 2006-04-04
WO2004087072A2 (en) 2004-10-14
US20050100519A1 (en) 2005-05-12
AU2004226324A1 (en) 2004-10-14
ZA200507824B (en) 2007-04-25
CN1964695A (zh) 2007-05-16
CA2519998A1 (en) 2004-10-14
EP1610760A4 (en) 2008-01-09
EA200501413A1 (ru) 2006-10-27
JP2006522807A (ja) 2006-10-05
KR20050113669A (ko) 2005-12-02

Similar Documents

Publication Publication Date Title
WO2004087072A3 (en) Topical l-carnitine compositions
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
AU6720300A (en) Compositions comprising conjugated linoleic acid (cla)
BRPI0514420A (pt) peptìdeo, variante do mesmo, ou um sal farmaceuticamente aceitável do mesmo, composição, uso de um peptìdeo ou de uma variante de peptìdeo, substrato, e, métodos de tratamento ou prevenção de um infecção microbiana, e de tratamento de uma ferida em um indivìduo
BR0010166A (pt) Composto modulador de ace-2, composto inibidor de ace-2, métodos para o tratamento de um estado associado a ace-2 em um paciente e para inibir a hidrólise de um peptìdeo de marcação de ace-2, e, composição farmacêutica
AU5249898A (en) N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
AU2002223058A1 (en) Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling
CA2374763A1 (en) Composition for improving skin lipid barrier function
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
SE0002202D0 (sv) New peptides
ATE304839T1 (de) Mittel zur erhöhung der hautlipiden produktion
EP1450771A4 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF TUMORS AND LESIONS OF SKIN AND MICE AND THESE METHOD AND KITS
WO2005090385A3 (en) Compositions having antimicrobial activity and uses thereof
AU3743499A (en) Phosphinic acid derivatives
BR0000897A (pt) Processo para a produção fermentativa de l-aminoácidos usando-se bactéria corineforme
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
AU2003249868A1 (en) Hair treatment compositions containing xanthine and alpha hydroxy acid
EP1219288A3 (en) Treatment for skin
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
ATE357454T1 (de) Verfahren zur herstellung tryptophanreicher peptide
DE60104695D1 (de) Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz
BR9306693A (pt) Processo para purificação de uma solução aquosa de enzima
GEP20043231B (en) Resorcinol Composition
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent

Legal Events

Date Code Title Description
FA Abandonment or withdrawal